Loading clinical trials...
Loading clinical trials...
Efficacy of Virtual Reality Mindfulness in Patients With Psychosis
This study is to evaluate the safety and efficacy of Virtual Reality Mindfulness in Patients With Psychosis.
This study is randomized, single-blind and parallel group trial to evaluate the safety and the efficacy of Virtual Reality Mindfulness in Patients With Psychosis once a week over 8 weeks treatment period. Both groups can experience the screen coming out of the head-mounted display for 30 minutes in a comfortable sitting position.
Age
15 - 59 years
Sex
ALL
Healthy Volunteers
Yes
Department of Psychiatry, Chonbuk National University Hospital
Jeonju, Jeollabuk-do, South Korea
Start Date
April 8, 2020
Primary Completion Date
June 9, 2021
Completion Date
June 9, 2021
Last Updated
April 10, 2023
67
ACTUAL participants
Virtual Reality Mindfulness Treatment
OTHER
Experience relaxing scenery and music
OTHER
Lead Sponsor
Chonbuk National University Hospital
NCT07455929
NCT06740383
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions